Archive for Март, 2008
Encouraging Acomplia Results Greeted With Mix of Excitement and Caution
Highly encouraging results reported November 9th from the largest trial to date of the new diet drug Acomplia (rimonabant) were greated with a mixture of excitement and caution by the medical community.
Data from a two-year study of rimonabant showed the drug helped obese patients [...]
Zimulti Acomplia Report Covers FDA Panel Meeting on Diet Pill Rimonabant
The make-or-break FDA advisory panel meeting on diet drug rimonabant ( Acomplia (rimonabant) ) will be the subject of team coverage on June 13th by staff of the Zimulti Acomplia , leading independent source of news about rimonabant.
The day-long meeting, which will air concerns [...]
New Patients Sought for Study of Acomplia Role in Curbing Alcohol Consumption
The National Institute on Alcohol Abuse and Alcoholism ( Acomplia (rimonabant) ) is continuing to seeking volunteers for a Phase II clinical trial exploring the potential of the promising obesity drug Acomplia (rimonabant) in curbing alcohol consumption.
A spokesperson for NIAAA said the trial of “Rimonabant [...]
Rimonabant Acomplia Side Effects
Rimonabant is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Obesity is now the most common nutritional disorder in western countries. Defined as a body mass index of greater than 30, it arises from the accumulation [...]
Encouraging Results Reported for Drug That Helps People Burn Body Fat
Acomplia (rimonabant) Metabolic Pharmaceuticals, Ltd, a biotech company, reported encouraging results for AOD9604A — a drug that stimulates the metabolism of body fat — in a small early-stage clinical trial in Australia.
Unveiling the results of a 300-patient phase 2b study, Metabolic said its [...]
Expert Says Overactive Endocannabinoid System May Be Key Factor in Obesity
Dr. Louis J. Aronne, a leading authority on obesity and long a strong supporter of diet drug rimonabant (Acomplia / Zimulti) , says “what many people have traditionally viewed as a lack of willpower [to stop eating] could actually have a biochemical basis” found in the endocannabinoid (EC) [...]
Researchers Convinced Variety of Drugs Needed to Beat Body’s Stockpiling of Fat
A growing number of scientists and doctors have become convinced Acomplia (rimonabant) that overcoming the body’s imperative to stockpile fat will require an assortment of drugs, mixed and matched in various combinations, and that many patients will be taking these cocktails for years — perhaps for life — along with dieting [...]
Study: Highly Encouraging Two-Year Trial Results Reported for Acomplia
The new diet drug rimonabant (Acomplia) helped people lose significantly more weight than a placebo in a two-year clinical trial, the largest of the studies of this drug conducted to date, according to researchers.
The study also showed that while most Acomplia (rimonabant) [...]
